CO4920235A1 - Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforilado - Google Patents
Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforiladoInfo
- Publication number
- CO4920235A1 CO4920235A1 CO97046477A CO97046477A CO4920235A1 CO 4920235 A1 CO4920235 A1 CO 4920235A1 CO 97046477 A CO97046477 A CO 97046477A CO 97046477 A CO97046477 A CO 97046477A CO 4920235 A1 CO4920235 A1 CO 4920235A1
- Authority
- CO
- Colombia
- Prior art keywords
- composition
- group
- mixtures
- amino acid
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/21—Synthetic spices, flavouring agents or condiments containing amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona con una composiciónalimenticia, en bebida, farmacéutica o de tocador que comprende por lo menos un activo farmacéutico oralmente administrable que tenga un sabor indeseable tal como amargo, metálico o mezcla de ellos y un aminoácido fosforilado seleccionado del grupo consistente de fosfotirosina, fosfoserina, fosfotreonina y mezclas de ellos. Una composición de acuerdo con la reivindicación 1, en donde dicho alimento, bebida, producto farmacéutico o producto de tocador tiene un sabor indeseable seleccionado del grupo consistente de amargo, metálico y mezclas de ellos. Una composición de acuerdo con la reivindicación 1, en donde el activo farmacéutico es seleccionado del grupo consistente de descongestionantes, expectorantes, antitusivos, antihistamínicos, broncodilatadores, demulcentes, agentes antiinflamatorios, antipiréticos, analgésicos, anestésicos, antimicrobianos, antibióticos, peróxidos, antibacterianos, agentes anticálculo, agentes anticaries, nutrientes, antiácidos, antagonistas receptores-H2, laxantes, antidiarréicos, anorexiantes, anticolinérgicos, antinauseantes, y mezclas de ellos, Una composición de acuerdo con la reivindicación 1, en donde dicha composición es seleccionada del grupo consistente de una composición para el tratamiento de síntomas de tos/resfriado, un dentífrico, un enjugue bucal, y una composición para el tratamiento de molestias gastrointestinales.Una composición de acuerdo con la reivindicación 4, en donde dicha composición es una composición para el tratamiento de síntomas de tos/resfriado que comprende por lo menos un activo farmacéutico oralmente administrable que tiene un sabor indeseable seleccionado del grupo consistente de descongestionantes, expectorantes, antitusivos, antihistamínicos, broncodilatadores, demulcentes, agentes antiinflamatorios, antipiréticos, analgésicos, anestésicos, y mezclas de ellos y dicho aminoácido fosforilado es seleccionado del grupo consistente de fosfotirosina, fosfoserina, fosfotreonina, y mezclas de ellos. Una composición de acuerdo con la reivindicación 5, en donde dicho aminoácido fosforilado es fosfotirosina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/696,711 US5766622A (en) | 1996-08-14 | 1996-08-14 | Inhibiting undesirable taste in oral compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4920235A1 true CO4920235A1 (es) | 2000-05-29 |
Family
ID=24798232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO97046477A CO4920235A1 (es) | 1996-08-14 | 1997-08-13 | Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforilado |
Country Status (21)
Country | Link |
---|---|
US (1) | US5766622A (es) |
EP (1) | EP1077726B1 (es) |
JP (1) | JP2001527518A (es) |
KR (1) | KR100323271B1 (es) |
CN (1) | CN1306440A (es) |
AR (1) | AR009079A1 (es) |
AT (1) | ATE234115T1 (es) |
AU (1) | AU724235B2 (es) |
BR (1) | BR9711159A (es) |
CA (1) | CA2263297C (es) |
CO (1) | CO4920235A1 (es) |
CZ (1) | CZ48199A3 (es) |
DE (1) | DE69719827T2 (es) |
HU (1) | HUP0103016A3 (es) |
ID (1) | ID19356A (es) |
IL (1) | IL128488A0 (es) |
NO (1) | NO990685L (es) |
PE (1) | PE100598A1 (es) |
TR (1) | TR199900300T2 (es) |
WO (1) | WO1998006436A2 (es) |
ZA (1) | ZA977082B (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6627233B1 (en) * | 1997-09-18 | 2003-09-30 | Wm. Wrigley Jr. Company | Chewing gum containing physiological cooling agents |
US6816934B2 (en) * | 2000-12-22 | 2004-11-09 | Hewlett-Packard Development Company, L.P. | Computer system with registered peripheral component interconnect device for processing extended commands and attributes according to a registered peripheral component interconnect protocol |
US6169118B1 (en) | 1998-11-12 | 2001-01-02 | Block Drug Company, Inc. | Flavor blend for masking unpleasant taste of zinc compounds |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
PE20020102A1 (es) * | 2000-06-30 | 2002-03-06 | Procter & Gamble | Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales |
US6391886B1 (en) * | 2000-12-04 | 2002-05-21 | The Procter & Gamble Company | Oral compositions having improved consumer aesthetics |
ITMI20012135A1 (it) * | 2001-10-16 | 2003-04-16 | Bioren S A | Soluzioni iniettabili pronte all'uso di paracetamolo |
US6887926B1 (en) | 2001-11-16 | 2005-05-03 | Oatey Co. | Bonding compositions for chlorinated polymers and methods of using the same |
US20040006111A1 (en) * | 2002-01-25 | 2004-01-08 | Kenneth Widder | Transmucosal delivery of proton pump inhibitors |
US7081264B2 (en) | 2002-04-26 | 2006-07-25 | Kraft Foods Holdings, Inc. | Process for debittering peanut hearts |
US6908637B2 (en) | 2002-04-26 | 2005-06-21 | Kraft Foods Holdings, Inc. | Process for debittering peanut hearts |
US20040091544A1 (en) * | 2002-11-08 | 2004-05-13 | Ruff Michael D. | Coated dibasic calcium phosphate |
CL2003002653A1 (es) * | 2002-12-18 | 2005-04-22 | Wyeth Corp | Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar |
EP1603537A4 (en) * | 2003-02-20 | 2009-11-04 | Santarus Inc | IMMEDIATE RELEASE OF OMEPRAZOLE ANTACIDAL COMPLEX WITH NEW FORMULATION FOR RAPID AND PROLONGED ELIMINATION OF GASTRIC ACID |
JP2006528182A (ja) * | 2003-07-18 | 2006-12-14 | サンタラス インコーポレイティッド | 薬学的製剤および酸に起因する消化器疾患の治療法 |
US20050084591A1 (en) * | 2003-10-20 | 2005-04-21 | Shukla Triveni P. | Soups comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid |
US20050084600A1 (en) * | 2003-10-20 | 2005-04-21 | Shukla Triveni P. | Dips comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid |
US20050238785A1 (en) * | 2003-10-20 | 2005-10-27 | Circle Group Holdings, Inc. | Sauces comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid |
US20050084589A1 (en) * | 2003-10-20 | 2005-04-21 | Shukla Triveni P. | Dressings comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid |
US20050084587A1 (en) * | 2003-10-20 | 2005-04-21 | Shukla Triveni P. | Ice creams comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
JP4435544B2 (ja) | 2003-11-19 | 2010-03-17 | 高砂香料工業株式会社 | 果汁含有飲料 |
US20050137262A1 (en) * | 2003-12-22 | 2005-06-23 | Hu Patrick C. | Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
EP1718164B1 (en) * | 2004-02-26 | 2010-09-29 | Wm. Wrigley Jr. Company | Confections containing a blend of physilogical cooling agents |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050287275A1 (en) * | 2004-06-28 | 2005-12-29 | Shukla Triveni P | Sauces comprising dietary fiber gel |
US20050287273A1 (en) * | 2004-06-28 | 2005-12-29 | Shukla Triveni P | Processed cheeses comprising dietary fiber gel |
US20060286268A1 (en) * | 2005-06-14 | 2006-12-21 | Circle Group Holdings, Inc. | Amorphous insoluble cellulosic fiber and method for making same |
WO2007100382A2 (en) * | 2005-10-27 | 2007-09-07 | Bernstein Lawrence R | Orally administrable gallium compositions and method of use |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US20070207206A1 (en) * | 2006-03-02 | 2007-09-06 | Rice Bronwyn C | Chewable pain formula |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
US8362083B2 (en) * | 2008-01-15 | 2013-01-29 | C.B. Fleet Company Inc. | Taste-masked docusate compositions |
EP2742350B1 (en) | 2011-08-08 | 2019-10-30 | The Coca-Cola Company | Cell lines comprising endogenous taste receptors and their uses |
US20160089439A1 (en) * | 2014-09-28 | 2016-03-31 | Satara Pharmaceuticals, LLC | Prevention of Illicit Manufacutre of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients |
BR112022019696A2 (pt) * | 2020-04-29 | 2022-11-22 | Nestle Sa | Produto nutricional contendo uma composição tampão e um aminoácido e métodos para uso de tal produto nutricional |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3140978A (en) * | 1961-11-02 | 1964-07-14 | Hoffmann La Roche | Pharmaceutical composition containing complex magnesium aluminum silicate |
US4031265A (en) * | 1975-06-18 | 1977-06-21 | The United States Of America As Represented By The Secretary Of Agriculture | Method of reducing bitterness in citrus juices |
US4248141A (en) * | 1978-08-18 | 1981-02-03 | Miller Jr Harry W | Method and apparatus for debittering soybeans |
CH635732A5 (fr) * | 1979-01-26 | 1983-04-29 | Nestle Sa | Procede de desamerisation d'un extrait de fruits ou de legumes et extrait desamerise obtenu. |
JPS56158707A (en) * | 1980-04-08 | 1981-12-07 | Lion Corp | Composition for oral use |
NZ199891A (en) * | 1981-03-04 | 1985-07-31 | Univ Melbourne | Caries-inhibiting compositions containing casein or x-s-casein or phosuitin |
US4517379A (en) * | 1981-06-26 | 1985-05-14 | Pfizer Inc. | Branched amides of L-aspartyl-D-amino acid dipeptides |
JPS59104310A (ja) * | 1982-12-07 | 1984-06-16 | Lion Corp | 口腔用組成物 |
US4581232A (en) * | 1983-07-20 | 1986-04-08 | Warner-Lambert Company | Magnesium trisilicate suitable for preparation of medicament adsorbates |
US5286489A (en) * | 1985-08-26 | 1994-02-15 | The Procter & Gamble Company | Taste masking compositions |
US5015628A (en) * | 1986-06-12 | 1991-05-14 | The University Of Melbourne | Anticariogenic phosphopeptides |
US5192563A (en) * | 1986-10-22 | 1993-03-09 | Wm. Wrigley, Jr. Company | Strongly mint-flavored chewing gums with reduced bitterness and harshness |
US5009819A (en) * | 1987-11-12 | 1991-04-23 | The Liposome Company, Inc. | Taste moderating composition |
US5266717A (en) * | 1989-04-03 | 1993-11-30 | Glenn Roy | N-(sulfomethyl)-N'arylureas |
US4994490A (en) * | 1989-04-03 | 1991-02-19 | The Nutrasweet Company | Novel N-(sulfomethyl)-N'-arylureas |
JPH0354921A (ja) * | 1989-07-24 | 1991-03-08 | Nec Corp | スケルチ信号発生回路 |
US5262179A (en) * | 1989-09-13 | 1993-11-16 | Nicholas Kiwi Pty Ltd. | Non-effervescent ibuprofen compositions |
JPH049335A (ja) * | 1990-04-25 | 1992-01-14 | Aamu:Kk | ギムネマ・シルベスタの苦味・渋味除去方法およびその飲用物 |
US5232735A (en) * | 1990-06-01 | 1993-08-03 | Bioresearch, Inc. | Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers |
US5024997A (en) * | 1990-06-22 | 1991-06-18 | American Home Products Corporation | Palatable ibuprofen solutions |
WO1992006991A1 (fr) * | 1990-10-15 | 1992-04-30 | Taisho Pharmaceutical Co., Ltd. | Erythromycine modifiee en 2' ou derive de cette substance |
JP3246738B2 (ja) * | 1990-11-30 | 2002-01-15 | ロート製薬株式会社 | サポニン及びアミノ酸含有組成物 |
US5336513A (en) * | 1991-02-20 | 1994-08-09 | Kraft General Foods, Inc. | Bitterness inhibitors |
JPH0515389A (ja) * | 1991-07-12 | 1993-01-26 | Terumo Corp | タンパク質様組成物の製造方法 |
DE4131118A1 (de) * | 1991-09-19 | 1993-03-25 | Henkel Kgaa | Verfahren zur herstellung geschmacksneutraler pasten von alkylethersulfaten in glycerin |
JPH0584288A (ja) * | 1991-09-25 | 1993-04-06 | Terumo Corp | 創傷被覆材 |
JPH07504810A (ja) * | 1991-11-27 | 1995-06-01 | バイオリサーチ・インコーポレイテツド | 特異的な可食物食味改質剤 |
DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
JP2615345B2 (ja) * | 1992-12-28 | 1997-05-28 | 三栄源エフ・エフ・アイ株式会社 | 呈味改善剤及び呈味改善方法 |
CN1065415C (zh) * | 1993-02-05 | 2001-05-09 | 花王株式会社 | 蛋白质和类脂复合体用于改善味觉的用途 |
US5407921A (en) * | 1993-07-01 | 1995-04-18 | Kao Corporation | Method for suppressing bitter taste |
-
1996
- 1996-08-14 US US08/696,711 patent/US5766622A/en not_active Expired - Fee Related
-
1997
- 1997-07-28 BR BR9711159A patent/BR9711159A/pt not_active IP Right Cessation
- 1997-07-28 WO PCT/US1997/013472 patent/WO1998006436A2/en not_active Application Discontinuation
- 1997-07-28 TR TR1999/00300T patent/TR199900300T2/xx unknown
- 1997-07-28 CA CA002263297A patent/CA2263297C/en not_active Expired - Fee Related
- 1997-07-28 CN CN97197342A patent/CN1306440A/zh active Pending
- 1997-07-28 EP EP97937072A patent/EP1077726B1/en not_active Expired - Lifetime
- 1997-07-28 HU HU0103016A patent/HUP0103016A3/hu unknown
- 1997-07-28 AT AT97937072T patent/ATE234115T1/de not_active IP Right Cessation
- 1997-07-28 KR KR1019997001291A patent/KR100323271B1/ko not_active IP Right Cessation
- 1997-07-28 JP JP50978598A patent/JP2001527518A/ja active Pending
- 1997-07-28 DE DE69719827T patent/DE69719827T2/de not_active Expired - Fee Related
- 1997-07-28 AU AU39676/97A patent/AU724235B2/en not_active Ceased
- 1997-07-28 CZ CZ99481A patent/CZ48199A3/cs unknown
- 1997-07-28 IL IL12848897A patent/IL128488A0/xx unknown
- 1997-08-08 ZA ZA9707082A patent/ZA977082B/xx unknown
- 1997-08-13 ID IDP972830A patent/ID19356A/id unknown
- 1997-08-13 AR ARP970103699A patent/AR009079A1/es not_active Application Discontinuation
- 1997-08-13 CO CO97046477A patent/CO4920235A1/es unknown
- 1997-08-14 PE PE1997000710A patent/PE100598A1/es not_active Application Discontinuation
-
1999
- 1999-02-12 NO NO990685A patent/NO990685L/no unknown
Also Published As
Publication number | Publication date |
---|---|
BR9711159A (pt) | 1999-08-17 |
DE69719827D1 (de) | 2003-04-17 |
ATE234115T1 (de) | 2003-03-15 |
NO990685L (no) | 1999-04-12 |
CZ48199A3 (cs) | 1999-06-16 |
IL128488A0 (en) | 2000-01-31 |
CA2263297C (en) | 2003-10-28 |
KR100323271B1 (ko) | 2002-02-06 |
WO1998006436A2 (en) | 1998-02-19 |
ID19356A (id) | 1998-07-02 |
US5766622A (en) | 1998-06-16 |
NO990685D0 (no) | 1999-02-12 |
ZA977082B (en) | 1998-03-04 |
EP1077726B1 (en) | 2003-03-12 |
AU724235B2 (en) | 2000-09-14 |
HUP0103016A2 (hu) | 2001-12-28 |
AU3967697A (en) | 1998-03-06 |
JP2001527518A (ja) | 2001-12-25 |
WO1998006436A3 (en) | 2000-12-21 |
KR20000030006A (ko) | 2000-05-25 |
PE100598A1 (es) | 1999-01-06 |
DE69719827T2 (de) | 2003-12-24 |
EP1077726A2 (en) | 2001-02-28 |
HUP0103016A3 (en) | 2002-06-28 |
CN1306440A (zh) | 2001-08-01 |
CA2263297A1 (en) | 1998-02-19 |
AR009079A1 (es) | 2000-03-08 |
TR199900300T2 (xx) | 1999-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4920235A1 (es) | Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforilado | |
AU727242B2 (en) | Antimicrobial compositions | |
US6689399B1 (en) | Transdermal delivery of an anti-inflammatory composition | |
CA2087146A1 (en) | Flavour-masked pharmaceutical compositions | |
WO2003013428A3 (en) | Nutritional supplements and methods of using same | |
EP1243274A3 (en) | Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract | |
DE122004000032I2 (de) | Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung | |
JPH03501605A (ja) | 痔疾並びにその他の治療用組成物 | |
HUP0003547A2 (hu) | Akut tüdőelváltozás és fibrózis kezelése alfavbéta6-antagonistákkal | |
US5541165A (en) | Saliva substitute | |
US5908613A (en) | Composition for the treatment and prevention of periodontal disease | |
US20020018773A1 (en) | Gastric emptying-promoting composition | |
US6589513B2 (en) | Oral hygiene formulation and method of use | |
CN111163762A (zh) | 组合物在预防和/或***治疗诱发的口腔和胃肠粘膜炎中的用途 | |
CN106265470A (zh) | 益生菌发酵复方草本牙膏 | |
US20080145461A1 (en) | Formulation and method of making a topical pain relief composition | |
Suriamah et al. | Effectiveness of toothpaste containing propolis, tea tree oil, and sodium monofluorophosphate against plaque and gingivitis | |
US5401728A (en) | Lecithin based topical liniment | |
US20130243702A1 (en) | Mouthwash Composition for Managing Oral Mucositis, Process and Methods Thereof | |
DE19502789A1 (de) | Arzneimittel | |
CA2429793A1 (en) | Interferon therapeutic effect enhancer | |
JPH0656677A (ja) | 制酸剤組成物 | |
EP1550443A4 (en) | COMPOSITION AGAINST STRESS-BASED DISEASES | |
GR3034142T3 (en) | Composition for the treatment or prevention of herpes | |
US20060216359A1 (en) | Topical preparation for treating ulcerations on the inside of the month |